Old Web
English
Sign In
Acemap
>
Paper
>
O11-3 Phase 2 trial of atezolizumab with bevacizumab for patients with PD-L1 high non-Sq NSCLC (WJOG10718L/At Be Study)
O11-3 Phase 2 trial of atezolizumab with bevacizumab for patients with PD-L1 high non-Sq NSCLC (WJOG10718L/At Be Study)
2021
Atsushi Nakamura
Takashi Seto
Hidetoshi Hayashi
Haruyasu Murakami
Seiji Niho
Terufumi Kato
Hideo Saka
Hiroshige Yoshioka
Isamu Okamoto
Koichi Azuma
Haruko Daga
Satoru Miura
Kazumi Nishino
Rie Tohnai
Nobuyuki Yamamoto
Kazuhiko Nakagawa
Keywords:
Bevacizumab
Oncology
Medicine
PD-L1
Phase (matter)
Internal medicine
Atezolizumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]